Mereo Biopharma Group earnings were -$43.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MREO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$7.0M, down 53% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MREO reported annual earnings of -$43.3M, with 46.8% growth. The next MREO earnings date is May 23, 2025.
Mereo Biopharma Group Earnings Reports & History FAQ
What were Mereo Biopharma Group's earnings last quarter?
Mereo Biopharma Group (NASDAQ: MREO) reported Q4 2024 earnings per share (EPS) of -$0.05, up 0% year over year. Total MREO earnings for the quarter were -$7.05 million. In the same quarter last year, Mereo Biopharma Group's earnings per share (EPS) was -$0.05.
The next MREO earnings date is Invalid Date. Add MREO to your watchlist to be reminded of Mereo Biopharma Group's next earnings date.
What was MREO's earnings growth in the past year?
As of Mereo Biopharma Group's earnings date in Q2 2025, Mereo Biopharma Group's earnings has grown year over year. MREO earnings in the past year totalled -$43.25 million.
Is Mereo Biopharma Group profitable or losing money?
As of the last Mereo Biopharma Group earnings report, Mereo Biopharma Group is currently losing money. Mereo Biopharma Group's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$43.25 million, a 46.79% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.